Lantern Pharma Inc. · NASDAQ:LTRN
Empery Asset Management, LP reported a 9.99% stake in Lantern Pharma Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 4, 2026
Empery Asset Management, LP reported a 9.99% stake in Lantern Pharma Inc., 1,322,551 shares, as a passive investor on Jun 30, 2026. Filed Aug 4, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 1,322,551
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Empery Asset Management, LP | 9.99% | 1,322,551 |
| Ryan M. Lane | 9.99% | 1,322,551 |
Source
Related
- Lantern Pharma Inc.
- Empery Asset Management, LP
- Lantern Pharma Inc. shareholders
- Schedule 13G/A · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G/A · Thomas A. Satterfield, Jr. · Jul 23, 2026
- Schedule 13D/A · BIOS Advisors GP, LLC · May 15, 2026
- Form 4 · Schalop Lee Troy · May 14, 2026
- Form 4 · Keyser D Jeffrey · May 14, 2026
- Schedule 13D/A · BIOS Advisors GP, LLC · Apr 16, 2026